About this trial
Hypnosis is a technique allowing the patient to focus his mental attention on a thought or a sensation, with the aim of reducing or modulating the intensity of a negative feeling or an ordeal encountered during the course of treatment. This tool can be used when patients are faced with chronic disorders (pain, anxiety, ...) or iatrogenic effects (nausea, asthenia, ...).
The patient is referred to hypnosis care by the doctor, psychologist or paramedics who follow him, when they detect a need.
Several scientific studies have shown the effectiveness of hypnosis in improving the quality of life of patients with breast cancer and in reducing pain during invasive procedures. On the other hand, in hematology, no research has measured the evolution of anxiety, over time, in patients receiving hypnotherapy.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients over 18 years old, fluent in French.
Patients starting hypnotherapy for anxiety disorders.
Anxiety score on the HADS scale (Hospital Anxiety and Depression Scale) greater than or equal to 8/21
Patients with diffuse large cell B-cell lymphoma or follicular lymphoma, whatever the stage of the disease.
Disqualifiers
Persons deprived of their liberty by a judicial or administrative decision
Adults subject to a legal protection measure
Trial design
Single group
Treatments tested in this trial
anxiety questionnaire
Other interventionPatient undergoing hypnosis session will have their anxiety measured just before the third session of hypnosis and after during a telephonic consultation. The result will be compared to the anxiety level before the first hypnosis session
Treatment groups
Trial outcomes
Primary outcomes
Evolution of anxiety
Difference in anxiety measured before starting hypnotherapy care and after 2 hypnosis sessions. It will be measured by the Hospital Anxiety and Depression Scale. This scale gives a score according to the level of anxiety ranging from 0 to 21. The higher the score, the more the patient is anxious.
Secondary outcomes
Evolution of anxiety before hypnotherapy and after 3 months of follow-up in hypnotherapy
Difference in anxiety measured before starting hypnotherapy care and after 3 hypnosis sessions. It will be measured by the Hospital Anxiety and Depression Scale. This scale gives a score according to the level of anxiety ranging from 0 to 21. The higher the score, the more the patient is anxious.
Evolution of anxiety between D0 and M3 according to the type of lymphoma
Difference in anxiety measured before starting hypnotherapy care and after 3 hypnosis sessions for two subgroups : follicular lymphoma and diffuse large b-cell lymphoma. It will be measured by the Hospital Anxiety and Depression Scale. This scale gives a score according to the level of anxiety ranging from 0 to 21. The higher the score, the more the patient is anxious.
Evolution of anxiety between D0 and W6 according to the type of lymphoma
Difference in anxiety measured before starting hypnotherapy care and after 2 hypnosis sessions for two subgroups : follicular lymphoma and diffuse large b-cell lymphoma. It will be measured by the Hospital Anxiety and Depression Scale. This scale gives a score according to the level of anxiety ranging from 0 to 21. The higher the score, the more the patient is anxious.
Evolution of anxiety between D0 and W6 according to the gender of the patient
Difference in anxiety measured before starting hypnotherapy care and after 2 hypnosis sessions for two subgroups : man and woman. It will be measured by the Hospital Anxiety and Depression Scale. This scale gives a score according to the level of anxiety ranging from 0 to 21. The higher the score, the more the patient is anxious.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.